Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.

Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J.

Am J Surg Pathol. 2002 Oct;26(10):1343-50.

PMID:
12360049
2.

Essential functions of Pax-5 (BSAP) in pro-B cell development.

Nutt SL, Thévenin C, Busslinger M.

Immunobiology. 1997 Dec;198(1-3):227-35. Review.

PMID:
9442394
3.

Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.

Morrison AM, Nutt SL, Thévenin C, Rolink A, Busslinger M.

Semin Immunol. 1998 Apr;10(2):133-42. Review.

PMID:
9618759
4.

Fidelity and infidelity in commitment to B-lymphocyte lineage development.

Rolink AG, Schaniel C, Busslinger M, Nutt SL, Melchers F.

Immunol Rev. 2000 Jun;175:104-11. Review.

PMID:
10933595
5.

Diagnostic uses of Pax5 immunohistochemistry.

Feldman AL, Dogan A.

Adv Anat Pathol. 2007 Sep;14(5):323-34. Review.

PMID:
17717432
6.

Immunophenotyping of hematologic neoplasms in paraffin-embedded tissue sections.

Davey FR, Elghetany MT, Kurec AS.

Am J Clin Pathol. 1990 Apr;93(4 Suppl 1):S17-26. Review.

PMID:
2180277
7.

Lymphoblastic lymphoma.

Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.

Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26. Review.

PMID:
21273093
8.

CD79: a review.

Chu PG, Arber DA.

Appl Immunohistochem Mol Morphol. 2001 Jun;9(2):97-106. Review.

PMID:
11396639
9.

Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.

Buettner M, Greiner A, Avramidou A, Jäck HM, Niedobitek G.

Hematol Oncol. 2005 Sep-Dec;23(3-4):127-32. Review.

PMID:
16342298
10.

Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.

Ozdemirli M, Fanburg-Smith JC, Hartmann DP, Shad AT, Lage JM, Magrath IT, Azumi N, Harris NL, Cossman J, Jaffe ES.

Am J Surg Pathol. 1998 Jul;22(7):795-804. Review.

PMID:
9669342
11.

Roles of EBF and Pax-5 in B lineage commitment and development.

Maier H, Hagman J.

Semin Immunol. 2002 Dec;14(6):415-22. Review.

PMID:
12457614
12.

[Effect of BSAP/Pax-5 on the development, proliferation and differentiation of B lymphocyte cell].

Tan YQ, Zhang YX.

Sheng Li Ke Xue Jin Zhan. 2001 Apr;32(2):125-8. Review. Chinese.

PMID:
12545881
13.

The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease.

O'Brien P, Morin P Jr, Ouellette RJ, Robichaud GA.

Cancer Res. 2011 Dec 15;71(24):7345-50. doi: 10.1158/0008-5472.CAN-11-1874. Epub 2011 Nov 29. Review.

14.

The role of Pax5 in leukemia: diagnosis and prognosis significance.

Shahjahani M, Norozi F, Ahmadzadeh A, Shahrabi S, Tavakoli F, Asnafi AA, Saki N.

Med Oncol. 2015 Jan;32(1):360. doi: 10.1007/s12032-014-0360-6. Epub 2014 Nov 27. Review.

PMID:
25428382
15.

Value of PAX 8 immunostaining in tumor diagnosis: a review and update.

Ordóñez NG.

Adv Anat Pathol. 2012 May;19(3):140-51. doi: 10.1097/PAP.0b013e318253465d. Review.

PMID:
22498579
16.

Plasticity of Pax-5(-/-) pre-B I cells.

Bruno L, Schaniel C, Rolink A.

Cells Tissues Organs. 2002;171(1):38-43. Review.

PMID:
12021490
17.

Coordinated expression of Pax-5 and FAK1 in metastasis.

Crapoulet N, O'Brien P, Ouellette RJ, Robichaud GA.

Anticancer Agents Med Chem. 2011 Sep;11(7):643-9. Review.

PMID:
21707507
18.

FOXO in B-cell lymphopoiesis and B cell neoplasia.

Ushmorov A, Wirth T.

Semin Cancer Biol. 2017 Jul 31. pii: S1044-579X(17)30151-7. doi: 10.1016/j.semcancer.2017.07.008. [Epub ahead of print] Review.

PMID:
28774833

Supplemental Content

Support Center